These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5465829)

  • 1. [Permeability of the erythrocyte membrane in hemolytic disease of the newborn].
    Dobronravov AV
    Vopr Okhr Materin Det; 1970 Jan; 15(1):19-23. PubMed ID: 5465829
    [No Abstract]   [Full Text] [Related]  

  • 2. [State of cellular permeability in hemolytic disease of the newborn and in certain hemolytic states in older children (review of the literature)].
    Dobronravov AV
    Vopr Okhr Materin Det; 1973 Jan; 18(6):56-9. PubMed ID: 4598199
    [No Abstract]   [Full Text] [Related]  

  • 3. [Metabolic aspects of pathology of erythrocytic membranes (literature survey)].
    Dobronravov AV; Novitskaia AV
    Vopr Okhr Materin Det; 1976 Apr; 21(4):20-4. PubMed ID: 136800
    [No Abstract]   [Full Text] [Related]  

  • 4. [Erythrocyte acetylcholinesterase activity in newborn infants with hemolytic disease due to ABO incompatibility].
    Sbraccia C; Carapella de Luca E; Bonanni V
    Minerva Pediatr; 1965 Oct; 17(29):1527-31. PubMed ID: 5892925
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnostic and prognostic significance of erythrocyte adenosine triphosphatase activity changes in hemolytic disease in the newborn].
    Osipov AI
    Vopr Okhr Materin Det; 1969 Feb; 14(2):90. PubMed ID: 4241957
    [No Abstract]   [Full Text] [Related]  

  • 6. [Behavior of erythrocytic acetylcholinesterase activity in the hemolytic disease of the newborn due to ABO incompatibility in relation to erythrocyte age].
    Gerlini G; Ottaviano S; Sbraccia C; Carapella E; Bonanni V
    Riv Clin Pediatr; 1968; 81(5):742-5. PubMed ID: 5754265
    [No Abstract]   [Full Text] [Related]  

  • 7. [The functional status of the adrenal cortex in healthy and hemolytic newborn infants].
    Bondar' MV; Sadovskaia AG; Ferdman TD
    Vopr Okhr Materin Det; 1967 Jan; 12(1):31-5. PubMed ID: 5628728
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diagnostic and prognostic significance of changes in adenosintriphosphatase activity of erythrocytes in hemolytic disease of the newborn].
    Osinov AI
    Vopr Okhr Materin Det; 1966 Feb; 11(2):19-23. PubMed ID: 4226874
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes in 6-phosphogluconate dehydrogenase activity of erythrocytes at various periods of childhood and in hemolytic disease of the newborn].
    Kovalev IuR
    Vopr Okhr Materin Det; 1971 Mar; 16(3):87-8. PubMed ID: 5104537
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intraerythrocytic potassium in newborn infants with hemolytic disease of the newborn].
    Töpke B; Menzel K; Wiedemann G
    Padiatr Grenzgeb; 1982; 21(3):171-8. PubMed ID: 6890198
    [No Abstract]   [Full Text] [Related]  

  • 11. [Consumption of antiglobulin on erythrocytes. II. Study of the erythrocytes of newborns suffering from hemolytic disease with the help of a technic using a system revealing a decreasing sensitivity].
    Guimbretière J; Guimbretière L
    Pathol Biol; 1966; 14(11):714-8. PubMed ID: 5328287
    [No Abstract]   [Full Text] [Related]  

  • 12. [Promethazine during pregnancy for hemolytic disease of the newborn].
    Bergman A; Yedwab GA; Avni A; David MP
    Harefuah; 1982 Mar; 102(6):221-3. PubMed ID: 7160713
    [No Abstract]   [Full Text] [Related]  

  • 13. [Activity of malate dehydrogenase in plasma and erythrocytes in hemolytic disease of the newborn].
    Borisova TZ
    Vopr Okhr Materin Det; 1970 Jan; 15(1):17-9. PubMed ID: 5465828
    [No Abstract]   [Full Text] [Related]  

  • 14. Study of adenosintriphosphatase activity of erythrocytes in newborns with hemolytic disease.
    Ossipov AI
    Indian Pediatr; 1972 Jul; 9(7):408-10. PubMed ID: 4265408
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the passage of fetal erythrocytes into the maternal circulation and prevention of perinatal hemolytic disease].
    Botella Llusiá J
    An R Acad Nac Med (Madr); 1966; 83(2):159-67. PubMed ID: 5952983
    [No Abstract]   [Full Text] [Related]  

  • 16. [Erythrocyte-gelatin test and the test of maternal serum with the erythrocytes of the newborn infant].
    Lepshina ZK
    Probl Gematol Pereliv Krovi; 1972 Jul; 17(7):58. PubMed ID: 4667316
    [No Abstract]   [Full Text] [Related]  

  • 17. [Structure of the surface of erythrocytes in a clot in hemolytic disease of the newborn].
    Mashanskiĭ VF; Lebskiĭ VK; Tsybul'kin EK; Shtil'bans VI
    Lab Delo; 1989; (2):20-2. PubMed ID: 2467050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of the use of erythrocytes from the newborn for the demonstration of anti-A and anti-B immune antibodies responsible for ABO hemolytic disease of the newborn].
    Ducos J; Bierme RS; Ohayon E; Marty Y
    Transfusion (Paris); 1967; 10(2):133-40. PubMed ID: 6070701
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanisms of hemolysis.
    Zipursky A
    Mead Johnson Symp Perinat Dev Med; 1982; (19):17-24. PubMed ID: 6821465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ATP activity of erythrocytes in children with hemolytic disease treated by exchange transfusions of Rh-positive blood].
    Osipov AI
    Vopr Okhr Materin Det; 1967 Jun; 12(7):23-5. PubMed ID: 5629284
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.